Qki Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of QKI mRNA CTD PMID:36331819 Qki Mouse (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of QKI mRNA CTD PMID:17997037 Qki Mouse 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of QKI mRNA CTD PMID:28960355 Qki Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of QKI mRNA CTD PMID:22206623 Qki Mouse 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of QKI mRNA CTD PMID:22206623 Qki Mouse 17beta-estradiol multiple interactions ISO QKI (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of QKI mRNA and [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of QKI mRNA CTD PMID:19619570 and PMID:21185374 Qki Mouse 17beta-estradiol decreases expression ISO QKI (Homo sapiens) 6480464 Estradiol results in decreased expression of QKI mRNA CTD PMID:19619570 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO QKI (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of QKI mRNA CTD PMID:19619570 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to QKI gene] CTD PMID:28213091 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of QKI mRNA CTD PMID:24680724 and PMID:28213091 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of QKI mRNA CTD PMID:16962184 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO QKI (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of QKI mRNA CTD PMID:22298810 Qki Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO QKI (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of QKI mRNA CTD PMID:19619570 Qki Mouse 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 Qki Mouse 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of QKI mRNA CTD PMID:18648102 Qki Mouse 4,4'-sulfonyldiphenol increases expression ISO QKI (Homo sapiens) 6480464 bisphenol S results in increased expression of QKI protein CTD PMID:34186270 Qki Mouse 6-propyl-2-thiouracil decreases expression ISO Qki (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of QKI mRNA CTD PMID:24780913 Qki Mouse aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of QKI mRNA CTD PMID:19770486 Qki Mouse all-trans-retinoic acid decreases expression ISO QKI (Homo sapiens) 6480464 Tretinoin results in decreased expression of QKI mRNA CTD PMID:21934132 Qki Mouse ammonium chloride affects expression ISO Qki (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of QKI mRNA CTD PMID:16483693 Qki Mouse aristolochic acid A decreases expression ISO QKI (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of QKI mRNA CTD PMID:33212167 Qki Mouse arsane affects methylation ISO QKI (Homo sapiens) 6480464 Arsenic affects the methylation of QKI gene CTD PMID:25304211 Qki Mouse arsenic atom affects methylation ISO QKI (Homo sapiens) 6480464 Arsenic affects the methylation of QKI gene CTD PMID:25304211 Qki Mouse arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of QKI protein CTD PMID:37955338 Qki Mouse arsenite(3-) multiple interactions ISO QKI (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to QKI mRNA] CTD PMID:32406909 Qki Mouse arsenous acid increases expression ISO QKI (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of QKI mRNA CTD PMID:20458559 Qki Mouse atrazine increases expression ISO QKI (Homo sapiens) 6480464 Atrazine results in increased expression of QKI mRNA CTD PMID:22378314 Qki Mouse benzo[a]pyrene decreases expression ISO QKI (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of QKI mRNA CTD PMID:20064835 Qki Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of QKI mRNA CTD PMID:19770486 Qki Mouse benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of QKI intron CTD PMID:27901495 Qki Mouse bis(2-ethylhexyl) phthalate decreases expression ISO QKI (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of QKI mRNA CTD PMID:31163220 Qki Mouse bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of QKI mRNA CTD PMID:33754040 Qki Mouse bisphenol A affects expression ISO Qki (Rattus norvegicus) 6480464 bisphenol A affects the expression of QKI mRNA CTD PMID:25181051 Qki Mouse bisphenol A increases expression ISO QKI (Homo sapiens) 6480464 bisphenol A results in increased expression of QKI protein CTD PMID:34186270 and PMID:37567409 Qki Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of QKI mRNA CTD PMID:33221593 Qki Mouse bisphenol A decreases expression ISO Qki (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of QKI mRNA CTD PMID:30816183 Qki Mouse bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of QKI mRNA CTD PMID:38685157 Qki Mouse butanal decreases expression ISO QKI (Homo sapiens) 6480464 butyraldehyde results in decreased expression of QKI mRNA CTD PMID:26079696 Qki Mouse C60 fullerene increases expression ISO Qki (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of QKI mRNA CTD PMID:19167457 Qki Mouse cadmium atom decreases expression ISO QKI (Homo sapiens) 6480464 Cadmium results in decreased expression of QKI mRNA CTD PMID:23369406 Qki Mouse cadmium dichloride increases expression ISO QKI (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of QKI mRNA CTD PMID:26472689 Qki Mouse cadmium dichloride decreases expression ISO QKI (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of QKI mRNA CTD PMID:38568856 Qki Mouse cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of QKI mRNA CTD PMID:24982889 Qki Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of QKI mRNA CTD PMID:25554681 Qki Mouse carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of QKI mRNA CTD PMID:25554681 Qki Mouse casticin decreases expression EXP 6480464 casticin results in decreased expression of QKI mRNA CTD PMID:28444820 Qki Mouse cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of QKI mRNA CTD PMID:21151649 Qki Mouse cobalt dichloride decreases expression ISO QKI (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of QKI mRNA CTD PMID:19320972 Qki Mouse copper atom multiple interactions ISO QKI (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of QKI mRNA CTD PMID:20971185 Qki Mouse copper(0) multiple interactions ISO QKI (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of QKI mRNA CTD PMID:20971185 Qki Mouse copper(II) chloride increases expression ISO QKI (Homo sapiens) 6480464 cupric chloride results in increased expression of QKI mRNA CTD PMID:17211630 Qki Mouse copper(II) sulfate increases expression ISO QKI (Homo sapiens) 6480464 Copper Sulfate results in increased expression of QKI mRNA CTD PMID:19549813 Qki Mouse crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of QKI mRNA CTD PMID:29279043 Qki Mouse Cuprizon decreases expression ISO Qki (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of QKI mRNA CTD PMID:27523638 Qki Mouse diarsenic trioxide increases expression ISO QKI (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of QKI mRNA CTD PMID:20458559 Qki Mouse Dibutyl phosphate affects expression ISO QKI (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of QKI mRNA CTD PMID:37042841 Qki Mouse dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of QKI mRNA CTD PMID:21266533 Qki Mouse diuron increases expression ISO Qki (Rattus norvegicus) 6480464 Diuron results in increased expression of QKI mRNA CTD PMID:21551480 Qki Mouse dorsomorphin multiple interactions ISO QKI (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Qki Mouse doxorubicin affects response to substance ISO QKI (Homo sapiens) 6480464 QKI protein affects the susceptibility to Doxorubicin CTD PMID:16217747 Qki Mouse doxorubicin decreases expression ISO QKI (Homo sapiens) 6480464 Doxorubicin results in decreased expression of QKI mRNA CTD PMID:29803840 Qki Mouse enzyme inhibitor multiple interactions ISO QKI (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of QKI protein CTD PMID:23301498 Qki Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of QKI mRNA CTD PMID:30319688 Qki Mouse ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of QKI mRNA CTD PMID:30319688 Qki Mouse ethyl methanesulfonate decreases expression ISO QKI (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of QKI mRNA CTD PMID:23649840 Qki Mouse folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of QKI mRNA CTD PMID:22206623 Qki Mouse folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of QKI mRNA CTD PMID:25629700 Qki Mouse formaldehyde increases expression ISO QKI (Homo sapiens) 6480464 Formaldehyde results in increased expression of QKI mRNA CTD PMID:20655997 Qki Mouse formaldehyde decreases expression ISO QKI (Homo sapiens) 6480464 Formaldehyde results in decreased expression of QKI mRNA CTD PMID:23649840 Qki Mouse haloperidol increases expression ISO QKI (Homo sapiens) 6480464 Haloperidol results in increased expression of QKI mRNA alternative form CTD PMID:19335891 Qki Mouse isotretinoin increases expression ISO QKI (Homo sapiens) 6480464 Isotretinoin results in increased expression of QKI mRNA CTD PMID:20436886 Qki Mouse ivermectin decreases expression ISO QKI (Homo sapiens) 6480464 Ivermectin results in decreased expression of QKI protein CTD PMID:32959892 Qki Mouse kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of QKI mRNA CTD PMID:17997037 Qki Mouse methoxychlor increases methylation ISO Qki (Rattus norvegicus) 6480464 Methoxychlor results in increased methylation of QKI gene CTD PMID:23303685 Qki Mouse methyl methanesulfonate decreases expression ISO QKI (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of QKI mRNA CTD PMID:23649840 Qki Mouse methylseleninic acid increases expression ISO QKI (Homo sapiens) 6480464 methylselenic acid results in increased expression of QKI mRNA CTD PMID:18548127 Qki Mouse miconazole decreases expression EXP 6480464 Miconazole results in decreased expression of QKI mRNA CTD PMID:27462272 Qki Mouse N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of QKI gene CTD PMID:16245024 Qki Mouse nicotine increases expression EXP 6480464 Nicotine results in increased expression of QKI mRNA CTD PMID:17997037 Qki Mouse ozone multiple interactions ISO QKI (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of QKI mRNA CTD PMID:35430440 Qki Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of QKI mRNA CTD PMID:36331819 Qki Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of QKI mRNA CTD PMID:23091169 Qki Mouse phenylmercury acetate multiple interactions ISO QKI (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA CTD PMID:27188386 Qki Mouse PhIP increases expression ISO Qki (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of QKI mRNA CTD PMID:15215175 Qki Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of QKI mRNA CTD PMID:18445702 Qki Mouse propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of QKI mRNA CTD PMID:21278054 Qki Mouse raloxifene multiple interactions ISO QKI (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of QKI mRNA CTD PMID:21185374 Qki Mouse resveratrol multiple interactions ISO QKI (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of QKI mRNA CTD PMID:23557933 Qki Mouse resveratrol decreases expression ISO Qki (Rattus norvegicus) 6480464 Resveratrol results in decreased expression of QKI mRNA CTD PMID:25905778 Qki Mouse SB 431542 multiple interactions ISO QKI (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 Qki Mouse sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of QKI mRNA CTD PMID:21795629 Qki Mouse sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of QKI mRNA CTD PMID:21795629 Qki Mouse sodium arsenite decreases expression ISO QKI (Homo sapiens) 6480464 sodium arsenite results in decreased expression of QKI mRNA and sodium arsenite results in decreased expression of QKI protein CTD PMID:29240254 Qki Mouse sodium arsenite multiple interactions ISO QKI (Homo sapiens) 6480464 MIR155 mRNA affects the reaction [sodium arsenite results in decreased expression of QKI mRNA] more ... CTD PMID:29240254 Qki Mouse sunitinib increases expression ISO QKI (Homo sapiens) 6480464 Sunitinib results in increased expression of QKI mRNA CTD PMID:31533062 Qki Mouse tamoxifen affects expression ISO QKI (Homo sapiens) 6480464 Tamoxifen affects the expression of QKI mRNA CTD PMID:14699072 Qki Mouse tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of QKI mRNA CTD PMID:28973375 Qki Mouse tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of QKI mRNA CTD PMID:17484886 Qki Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of QKI mRNA CTD PMID:23557971 Qki Mouse titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of QKI mRNA CTD PMID:17656681 Qki Mouse topotecan affects response to substance ISO QKI (Homo sapiens) 6480464 QKI protein affects the susceptibility to Topotecan CTD PMID:16217747 Qki Mouse trichostatin A decreases expression ISO QKI (Homo sapiens) 6480464 trichostatin A results in decreased expression of QKI mRNA CTD PMID:24935251 Qki Mouse trichostatin A multiple interactions ISO QKI (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA CTD PMID:27188386 Qki Mouse trichostatin A increases expression ISO QKI (Homo sapiens) 6480464 trichostatin A results in increased expression of QKI mRNA CTD PMID:24935251 and PMID:26272509 Qki Mouse triphenyl phosphate affects expression ISO QKI (Homo sapiens) 6480464 triphenyl phosphate affects the expression of QKI mRNA CTD PMID:37042841 Qki Mouse troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of QKI mRNA CTD PMID:28973697 Qki Mouse troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of QKI mRNA CTD PMID:12732648 Qki Mouse valproic acid increases methylation ISO QKI (Homo sapiens) 6480464 Valproic Acid results in increased methylation of QKI gene CTD PMID:29154799 Qki Mouse valproic acid multiple interactions ISO QKI (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA CTD PMID:27188386 Qki Mouse valproic acid increases expression ISO QKI (Homo sapiens) 6480464 Valproic Acid results in increased expression of QKI mRNA CTD PMID:23179753 and PMID:26272509 Qki Mouse valproic acid decreases expression ISO QKI (Homo sapiens) 6480464 Valproic Acid results in decreased expression of QKI mRNA CTD PMID:23179753 more ... Qki Mouse valproic acid affects expression ISO QKI (Homo sapiens) 6480464 Valproic Acid affects the expression of QKI mRNA CTD PMID:25979313 Qki Mouse vinclozolin affects expression ISO Qki (Rattus norvegicus) 6480464 vinclozolin affects the expression of QKI mRNA CTD PMID:19015723 Qki Mouse vinclozolin decreases expression ISO Qki (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of QKI mRNA CTD PMID:22570695